Although there has been evidence of CRYAB's effect on tumor prognosis and tumor-infiltrating lymphocytes, it has only been limited to a few tumors, and there has been no comprehensive pan-cancer analysis based on TCGA and GO. The gene discussed is CRYAB; the disease is cancer.